Voxel-wise analysis of diffusion weighted imaging reveals disruption of the olfactory tract in Parkinson's disease
Authors:
- Christoph ScherflerCSChristoph Scherfler
- Michael F. SchockeMSMichael F. Schocke
- Klaus SeppiKSKlaus Seppi
- Regina EsterhammerRERegina Esterhammer
- Christian BrenneisCBChristian Brenneis
- Werner JaschkeWJWerner Jaschke
- Gregor K. WenningGWGregor K. Wenning
- Werner PoeweWPWerner Poewe
Open Access
- 4 November 2005
- journal article
- research article
- Published by Oxford University Press (OUP) in Brain
- Vol. 129 (2) , 538-542
Abstract
Diffusion weighted imaging (DWI) and the trace of diffusion tensor [Trace (D)], a marker of water molecule diffusivity, provide information on structural integrity of nervous tissues. To investigate structural lesions within the brain's neuronal architecture in early stages of Parkinson's disease, 12 patients with disease duration of 3.5 ± 1.5 years were studied with DWI. Data were compared with 12 age-matched healthy control subjects. To objectively localize focal changes of structural neuronal integrity without having to make an a priori hypothesis as to its location statistical parametric mapping (SPM) was applied to our DWI study. SPM localized significant increases of diffusivity in the region of both olfactory tracts in patients (P < 0.001). Trace (D) cut-off values for the voxel cluster of the olfactory tracts have been calculated from the subjects entered into SPM and applied to a total of 17 different individuals (9 patients with Parkinson's disease, disease duration 3.1 ± 1.3 years and 8 age-matched healthy subjects). Out of 17 subjects, 16 subjects, i.e. 94%, were correctly discriminated with a sensitivity of 100% and a specificity of 88%. All patients with Parkinson's disease were correctly classified and only one normal subject was classified as having the disease, underlining the high potential of this method to separate patients with the illness from healthy subjects. Increased diffusivity in the olfactory tract is in line with the well-established clinical finding of hyposmia in Parkinson's disease. Whether DWI can be used as a marker to identify individuals at risk to develop this disease remains to be shown.Keywords
This publication has 26 references indexed in Scilit:
- Brainstem neurodegeneration correlates with clinical dysfunction in SCA1 but not in SCA2. A quantitative volumetric, diffusion and proton spectroscopy MR studyBrain, 2004
- ADC mapping of neurodegeneration in the brainstem and cerebellum of patients with progressive ataxiasNeuroImage, 2004
- Differentiation of idiopathic Parkinson's disease, multiple system atrophy, progressive supranuclear palsy, and healthy controls using magnetization transfer imagingNeuroImage, 2004
- Voxel‐based morphometry detects cortical atrophy in the Parkinson variant of multiple system atrophyMovement Disorders, 2003
- Staging of brain pathology related to sporadic Parkinson’s diseaseNeurobiology of Aging, 2003
- The substantia nigra of the human brainBrain, 1999
- Spatial registration and normalization of imagesHuman Brain Mapping, 1995
- Bilateral olfactory dysfunction in early stage treated and untreated idiopathic Parkinson's disease.Journal of Neurology, Neurosurgery & Psychiatry, 1992
- Olfactory dysfunction in parkinsonismNeurology, 1988
- Olfactory function in patients with Parkinson's diseaseJournal of Chronic Diseases, 1975